These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9168448)

  • 21. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L
    Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.
    Rosenberg JD; Burian C; Waalen J; Saven A
    Blood; 2014 Jan; 123(2):177-83. PubMed ID: 24192579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience.
    Chadha P; Rademaker AW; Mendiratta P; Kim B; Evanchuk DM; Hakimian D; Peterson LC; Tallman MS
    Blood; 2005 Jul; 106(1):241-6. PubMed ID: 15761021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
    von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
    Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
    Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 33. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
    Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem.
    Dann EJ; Gillis S; Rachmilewitz EA; Barak V; Cass Y; Ruchlemer R; Polliack A
    Leuk Lymphoma; 1994; 14 Suppl 1():127-31. PubMed ID: 7820044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA).
    Robak T; Krykowski E; Błasińska-Morawiec M; Urbańska-Ryś H
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):25-9. PubMed ID: 7503629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Chrobák L; Zák P; Podzimek K; Plísková L; Foglová J; Maisnar V; Dulícek P; Dĕdic K
    Acta Medica (Hradec Kralove); 1997; 40(2):41-5. PubMed ID: 9389210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Zinzani PL; Tura S
    Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panuveitis responsive to 2-CdA: an unusual ocular presentation of hairy cell leukemia.
    Zeidman A; Floru S; Robinson A; Polliack A; Djaldeti M; Savir H; Mittelman M
    Leuk Lymphoma; 1996 Feb; 20(5-6):501-3. PubMed ID: 8833410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.